AN ACT Relating to expanding the drugs eligible for the unexpired prescription drug donation program;
Summary
HB1849 expands Washington’s unexpired prescription drug donation program by broadening the kinds of prescription drugs and supplies that may be accepted, inspected, and dispensed through participating pharmacies. Under the bill, donated medications may be accepted if they remain in original sealed, tamper-evident packaging, or if they are opened but contain intact single-unit doses, and if they are not expired and still have sufficient remaining shelf life. The bill also requires a pharmacist to inspect donated drugs or supplies before dispensing them and to determine that they are not adulterated or misbranded, while also meeting any additional safety precautions established by the Department of Health.
The bill adds operational rules for recalls and distribution. Donors must notify a pharmacy if they learn donated drugs have been recalled, and pharmacies or other entities that receive recall notices must remove recalled medications from stock and follow recall instructions. Donated prescription drugs and supplies may not be resold, and any drugs or supplies dispensed through the program are not eligible for reimbursement by public or private health care payers. The bill also limits distribution of drugs that are subject to manufacturer registration programs, unless the receiving patient is properly registered and the dispensed amount does not exceed the registration period.
Impact
HB1849 amends RCW provisions governing the prescription drug donation program to increase the range of eligible donated medications and supplies and to clarify safety, recall, and dispensing requirements. It affects pharmacies, pharmacists, donors, and eligible recipients by setting conditions for acceptance, inspection, distribution, and handling of recalled products, while preserving existing restrictions on resale and reimbursement. The bill would likely increase access to donated medications for eligible individuals while maintaining regulatory oversight through pharmacy inspection and Department of Health safety standards.
Sentiment
The bill appears generally supportive and practical in tone, with the caption emphasizing expansion of access to donated prescription drugs. Although no committee transcript or vote record is provided, the text suggests a public-health and access-to-medicine rationale rather than a controversial policy shift. The absence of recorded opposition or amendments in the provided materials indicates no documented division in the available record.
Contention
The main policy tensions are between expanding access to donated medications and ensuring patient safety and regulatory compliance. Potential concerns include whether opened packages and longer-expiration donations create quality risks, how recall notifications will be tracked and enforced, and whether the prohibition on reimbursement could limit participation by pharmacies or donors. Another possible point of concern is the restriction on drugs tied to manufacturer registration programs, which may complicate distribution for certain specialty medications.
Revised for engrossed: Removing a tax exemption for the warehousing and reselling of prescription drugs and providing tax relief for critical access pharmacies.